Published online before print September 13, 2001, doi: 10.1161/hh2101.098372
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2001 American Heart Association, Inc.
Cellular Biology |
Ischemic and Pharmacological Preconditioning in Girardi Cells and C2C12 Myotubes Induce Mitochondrial Uncoupling
From the Hatter Institute for Cardiology Research, MRC Inter-University Cape Heart Group (J.M., L.L., J.McC., J.J.M., M.N.S.), University of Cape Town Medical School, Cape Town, South Africa; and the Hatter Institute for Cardiovascular Studies (D.M.Y.), University College Hospitals and Medical School, London, United Kingdom.
Correspondence to Michael N. Sack, MD, PhD, Hatter Institute for Cardiology Research, UCT Medical School, Observatory 7925, Cape Town, South Africa. E-mail sack{at}capeheart.uct.ac.za
Pharmacological uncoupling of mitochondrial oxidation from phosphorylation promotes preconditioning-like cardioprotection in the isolated rat heart. We hypothesized that modest mitochondrial uncoupling may be a critical cellular event in orchestrating preconditioning. Human-derived Girardi cells and murine C2C12 skeletal myotubes were preconditioned using simulated ischemia, adenosine, and diazoxide. Cell viability after 6 hours of simulated ischemia was measured using lactate dehydrogenase release and propidium iodide uptake. Mitochondrial inner membrane potential (
m) was investigated by flow cytometry, cellular ATP by recombinant firefly-luciferase bioluminescence, and cellular oxygen consumption using oximetry. Preconditioning enhanced cell viability with attenuation of lactate dehydrogenase release (
30%, P<0.05 versus ischemic controls) and a reduction in propidium iodide uptake by 26% versus ischemic controls after simulated ischemia in both cell lines. In Girardi cells, preconditioning induced the following phenotype immediately before index ischemia: (1) decreased m (JC-1: simulated ischemia 90±3%, adenosine 82±7%, diazoxide 87±4%, versus control 100%, P<0.05); (2) attenuation in cellular ATP levels (CTL 0.21±0.03 nmol/L ATP/µg protein, simulated ischemia 0.12±0.02, adenosine 0.15±0.02, diazoxide 0.11±0.02, P<0.05); and (3) enhanced cellular oxygen consumption (control 2.3±0.1 nmol/L oxygen/min/1x106 cells, simulated ischemia 3.1±0.1, adenosine 3.1±0.3, diazoxide 2.6±0.2, P<0.05). Cytoprotection, mitochondrial depolarization, and enhanced oxygen consumption were attenuated by the putative mitochondrial KATP-channel antagonist 5-hydroxydecanoate. The uncoupled phenotype in response to preconditioning was similarly observed in C2C12 myotubes. The present study suggests that modest mitochondrial uncoupling represents a unifying cellular response which may be important in directing preconditioning-mediated cytoprotection.
Key Words: preconditioning • mitochondrial function • mitochondrial membrane potential • ATP • oxygen consumption
This article has been cited by other articles:
 |
|
 |
|
  C. Tanaka-Esposito, Q. Chen, S. Moghaddas, and E. J. Lesnefsky Ischemic preconditioning does not protect via blockade of electron transport J Appl Physiol, August 1, 2007; 103(2): 623 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Westberg, M. Serlachius, P. Lankila, M. Penkowa, J. Hidalgo, and L. C. Andersson Hypoxic Preconditioning Induces Neuroprotective Stanniocalcin-1 in Brain via IL-6 Signaling Stroke, March 1, 2007; 38(3): 1025 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Comelli, G. Metelli, and I. Mavelli Downmodulation of mitochondrial F0F1 ATP synthase by diazoxide in cardiac myoblasts: a dual effect of the drug Am J Physiol Heart Circ Physiol, February 1, 2007; 292(2): H820 - H829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Heinen, A. K. S. Camara, M. Aldakkak, S. S. Rhodes, M. L. Riess, and D. F. Stowe Mitochondrial Ca2+-induced K+ influx increases respiration and enhances ROS production while maintaining membrane potential Am J Physiol Cell Physiol, January 1, 2007; 292(1): C148 - C156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Sack Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance Cardiovasc Res, November 1, 2006; 72(2): 210 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Brennan, R. Southworth, R. A. Medina, S. M. Davidson, M. R. Duchen, and M. J. Shattock Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation Cardiovasc Res, November 1, 2006; 72(2): 313 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Brennan, R. G. Berry, M. Baghai, M. R. Duchen, and M. J. Shattock FCCP is cardioprotective at concentrations that cause mitochondrial oxidation without detectable depolarisation Cardiovasc Res, November 1, 2006; 72(2): 322 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Sack Exploring Mitochondria in the Intact Ischemic Heart: Advancing Technologies to Image Intracellular Function Circulation, October 3, 2006; 114(14): 1452 - 1454. [Full Text] [PDF]
|
|
|
|
|
|
S. Lecour, N. Suleman, G. A. Deuchar, S. Somers, L. Lacerda, B. Huisamen, and L. H. Opie Pharmacological Preconditioning With Tumor Necrosis Factor-{alpha} Activates Signal Transducer and Activator of Transcription-3 at Reperfusion Without Involving Classic Prosurvival Kinases (Akt and Extracellular Signal-Regulated Kinase) Circulation, December 20, 2005; 112(25): 3911 - 3918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. McLeod, A. Aziz, R. F. Hoyt Jr., J. P. McCoy Jr., and M. N. Sack Uncoupling Proteins 2 and 3 Function in Concert to Augment Tolerance to Cardiac Ischemia J. Biol. Chem., September 30, 2005; 280(39): 33470 - 33476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Rongen, W. J.G. Oyen, B. P. Ramakers, N. P. Riksen, O. C. Boerman, N. Steinmetz, and P. Smits Annexin A5 Scintigraphy of Forearm as a Novel In Vivo Model of Skeletal Muscle Preconditioning in Humans Circulation, January 18, 2005; 111(2): 173 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Smith, N. Suleman, L. Lacerda, L. H. Opie, S. Akira, K. R. Chien, and M. N. Sack Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning Cardiovasc Res, September 1, 2004; 63(4): 611 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. McLeod, A. P. Jeyabalan, J. O. Minners, R. Clevenger, R. F. Hoyt Jr, and M. N. Sack Delayed Ischemic Preconditioning Activates Nuclear-Encoded Electron-Transfer-Chain Gene Expression in Parallel With Enhanced Postanoxic Mitochondrial Respiratory Recovery Circulation, August 3, 2004; 110(5): 534 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hausenloy, A. Wynne, M. Duchen, and D. Yellon Transient Mitochondrial Permeability Transition Pore Opening Mediates Preconditioning-Induced Protection Circulation, April 13, 2004; 109(14): 1714 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Opie Preconditioning and metabolic anti-ischaemic agents Eur. Heart J., October 2, 2003; 24(20): 1854 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Minners, C. J. McLeod, and M. N. Sack Mitochondrial plasticity in classical ischemic preconditioning--moving beyond the mitochondrial KATP channel Cardiovasc Res, July 1, 2003; 59(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ichinose, H. Yonemochi, T. Sato, and T. Saikawa Diazoxide triggers cardioprotection against apoptosis induced by oxidative stress Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2235 - H2241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Katoh, N. Nishigaki, and H. Hayashi Diazoxide Opens the Mitochondrial Permeability Transition Pore and Alters Ca2+ Transients in Rat Ventricular Myocytes Circulation, June 4, 2002; 105(22): 2666 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P. Dzeja, E. L. Holmuhamedov, C. Ozcan, D. Pucar, A. Jahangir, and A. Terzic Mitochondria: Gateway for Cytoprotection Circ. Res., October 26, 2001; 89(9): 744 - 746. [Full Text] [PDF]
|
|